Over the last five years, nearly all of the major information
technology companies have launched some sort of healthcare initiative. The
COVID pandemic, with its surging demand for telemedicine and rapid exchange of medical
data, only intensifed that trend.
But some tech giants have learned the hard way that healthcare is
very different from other business sectors.
What is the common theme underlying nearly all of the diseases associated with aging? Mitochondrial dysfunction. It is a simple biological fact that mitochondrial function tends to decline with age. This affects every organ and every tissue in the body. But clinicians often fail to consider “mitochondriopathy” as they treat the various diseases that their […]
Over the last five years, nearly all of the major information technology companies have launched some sort of healthcare initiative. The COVID pandemic, with its surging demand for telemedicine and rapid exchange of medical data, only intensifed that trend. But some tech giants have learned the hard way that healthcare is very different from other […]
could be just what your patients need for a better life. Pre- and probiotics
have become mainstream solutions for improved overall wellbeing, but research
has revealed that paraprobiotics–heat-killed probiotic strains–can also have
very specific benefits. Paraprobiotics also deliver the added advantage of a
longer shelf-life without the need for refrigeration.
free webinar, Danielle Citrolo, PharmD, and Shintaro Ichikawa, PhD, will
discuss how paraprobiotics will benefit your patients. They will introduce you
to IMMUSE and EYEMUSE, two branded forms of clinically studied strains that help
to bolster immune function and vision by stimulating immune cells within the
gut and the retina. IMMUSE is currently supported by eleven human trials and
EYEMUSE is supported by two studies.
webinar, you will:
understanding of what are paraprobiotics, and why they could be a good
alternative to probiotic strains in your practice.
importance of the immune system and its role in overall health.
the ability of paraprobiotics to influence the immune system for improved
the published clinical research behind the unique paraprobiotic strains used
for IMMUSE and EYEMUSE.
Citrolo, PharmD is a registered pharmacist who
provides scientific and regulatory support to
Kyowa’s customers in the US, Canada and Latin America. She holds degrees in
biochemistry and chemistry from North Carolina State University and a Doctor of
Pharmacy from Albany College of Pharmacy, NY.
Ichikawa, PhD, is the Director of Technical Affairs
at Kyowa Hakko USA. He is leading the launch of IMMUSE™, the company’s unique
Lactococcus lactis strain, in the United States. He previously led the launch
of IMMUSE™ in Japan. Dr. Ichikawa holds a Doctorate in Life Science from the
University of Tokyo, Department of Applied Biochemistry.